Major pathological response after neoadjuvant immunotherapy in esophageal spindle cell carcinoma: A case report

Esophageal spindle cell carcinoma (ESpCC) is a rare subtype of esophageal carcinoma, accounting for 1% of all esophageal malignancies. The clinical outcome is unknown due to the lack of treatment options. Here, we present the case of a 60‐year‐old male with initially unresectable ESpCC, in which pla...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Yang, Wang, Pei‐Pei, He, Du, Zheng, Yue, Ding, Zhen‐Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8046125/
https://www.ncbi.nlm.nih.gov/pubmed/33619875
http://dx.doi.org/10.1111/1759-7714.13905

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8046125/
https://www.ncbi.nlm.nih.gov/pubmed/33619875
http://dx.doi.org/10.1111/1759-7714.13905

Ejemplares similares